SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367644-07-000024
Filing Date
2007-05-10
Accepted
2007-05-10 13:20:19
Documents
8
Period of Report
2007-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k_051007.htm 8-K 13926
2 ex99_earningsq1.htm EX-99 22512
3 GRAPHIC img1.gif GRAPHIC 6499
4 GRAPHIC img2.gif GRAPHIC 13635
5 GRAPHIC img3.jpg GRAPHIC 2329
6 GRAPHIC img4.jpg GRAPHIC 2329
7 GRAPHIC img5.jpg GRAPHIC 4620
8 GRAPHIC img6.jpg GRAPHIC 1914
  Complete submission text file 0001367644-07-000024.txt   81911
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 07836348
SIC: 2834 Pharmaceutical Preparations